INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 451m ago
House PTR51m ago
SEC 13F51m ago
Robinhood Chain51m ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Form 4 transactions

65,929 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
26
JD
Jedda DanCFO & COO
ROKUROKU, INC
Open-market sale · 10b5-1 plan
SELL$1.07M
7,000 sh
Oct 15, 2026Oct 19, 2026
Page 153 of 1649
← PrevNext →
traded Oct 15, 2026
+4d
SEC Form 4

Evidence

26
KP
Kirol Charles PeterChief Operating Officer
PTONPELOTON INTERACTIVE, INC.
Open-market sale
SELL$154K
28.8K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

26
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$177K
900 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

25
MR
McCrystle Kevin RossDirector, CEO
GRSDGRANDSTAND Ltd
Open-market purchase
BUY$3,365
2,901 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

25
BL
Borck LeonDirector
EQBKEQUITY BANCSHARES INC
Open-market purchase
BUY$19K
380 sh
Oct 19, 2026Oct 19, 2026
traded Oct 19, 2026
+0dSEC Form 4

Evidence

25
RS
Rajasekar SunilEVP Chief Prod & Strat Officer
HQYHEALTHEQUITY, INC.
Open-market purchase
BUY$9,756
108 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

23
GD
Gus DanielGeneral Counsel & Secretary
EBFENNIS, INC.
Option exercise
M$45K
2,603 sh
Oct 6, 2026Oct 19, 2026
traded Oct 6, 2026
+13dSEC Form 4

Evidence

23
HA
How AntoinetteChief Accounting Officer
NXDRNextdoor Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$52K
20.7K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

23
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$20K
100 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

23
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Option exercise
M$310K
16.1K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

22
TA
Toy AndrewDirector, Chief Executive Officer
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$291K
62.2K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

21
BF
Baumgartner FlorianEVP and CEO, Vista
CMPRCIMPRESS plc
Option exercise
M—
1,025 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

21
SP
Siegrist Jonathan PhilipEVP of R&D & CTO
QDELQuidelOrtho Corp
Option exercise
M—
18.7K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

21
MH
Misto Holdings Corp.Director, 10% Owner
GOLFAcushnet Holdings Corp.
Disposition to issuer
D$52.50M
583.5K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

21
PI
Ponnambalam IndrajitCFO and Treasurer
NXDRNextdoor Holdings, Inc.
Option exercise
M—
103.2K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

21
DL
Dean LiaPres, Banking & Prem. Products
COFCAPITAL ONE FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$370K
1,887 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

21
OG
Orchard GlennChief Growth Officer
ANGIAngi Inc.
Option exercise
M—
10.0K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

21
SS
Shani ShaulDirector
RBBNRibbon Communications Inc.
Option exercise
M—
185.2K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

21
WY
Woo Ian YingDirector
NBPNovaBridge Biosciences
Option exercise
M—
5,770 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

21
OG
Orchard GlennChief Growth Officer
ANGIAngi Inc.
Option exercise
M—
10.0K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

21
KC
Karam CeliaPres, Retail Bank
COFCAPITAL ONE FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$377K
1,927 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

20
CD
Comerchero Marc D.Principal Accounting Officer
BLKBlackRock, Inc.
Other acquisition or disposition
J—
1,192 sh
Oct 19, 2026Oct 19, 2026
traded Oct 19, 2026
+0dSEC Form 4

Evidence

20
PI
Ponnambalam IndrajitCFO and Treasurer
NXDRNextdoor Holdings, Inc.
Tax withholding
F$106K
40.6K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

20
TC
Thornton Joseph ClayInterim CFO
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$21K
4,591 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

20
SP
Siegrist Jonathan PhilipEVP of R&D & CTO
QDELQuidelOrtho Corp
Tax withholding
F$93K
6,695 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

20
CE
Cohen EyalDirector, CEO
BOSCBOS BETTER ONLINE SOLUTIONS LTD
Option exercise
M$101K
31.1K sh
Oct 19, 2026Oct 19, 2026
traded Oct 19, 2026
+0dSEC Form 4

Evidence

19
SK
Soares KarenChief Legal Officer
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$69K
14.7K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

19
KM
Kumar MukulPRESIDENT, ENGINEERING
PUBMPubMatic, Inc.
Open-market sale · 10b5-1 plan
SELL$91K
5,400 sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

19
WC
Wai ConradCEO, Counterpart Health
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$111K
23.6K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

19
GD
Gus DanielGeneral Counsel & Secretary
EBFENNIS, INC.
Option exercise
M$45K
2,603 sh
Oct 6, 2026Oct 19, 2026
traded Oct 6, 2026
+13dSEC Form 4

Evidence

19
GB
Gage BrodieEVP & Chief Product & Tech
CIENCIENA CORP
Open-market sale · 10b5-1 plan
SELL$413K
1,200 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

19
TN
Tolia Nirav NDirector, CEO and President, 10% Owner
NXDRNextdoor Holdings, Inc.
Tax withholding
F$320K
123.2K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

18
SS
Schwartz SophiaChief Legal Officer, Secretary
NXDRNextdoor Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$121K
48.1K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

17
LW
Lozinski Jeffrey William10% Owner
KSEZKinetic Seas Inc.
Open-market sale
SELL$2,838
114.9K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

17
RL
Rachlin Evan LockwoodDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
410.8K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

17
SM
Secora MichaelCFO & Chief Corp Dev Ofcr
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
61.3K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

17
PJ
Plovanic William J.Director
TELATELA Bio, Inc.
Grant or award
A$16K
16.1K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

17
LC
Lisowski CraigPresident of Products
NXDRNextdoor Holdings, Inc.
Option exercise
M—
178.6K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

17
OG
Orchard GlennChief Growth Officer
ANGIAngi Inc.
Tax withholding
F$29K
4,466 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

16
DD
DiPerna DinoEVP & Chief R&D Officer
CIENCIENA CORP
Open-market sale · 10b5-1 plan
SELL$153K
445 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  7. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  8. SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K